1. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22). Issue 6 (June 2020) Authors: Stephenson, Kathryn E; Wegmann, Frank; Tomaka, Frank; Walsh, Stephen R; Tan, C Sabrina; Lavreys, Ludo; Ansel, Jessica L; Kanjilal, Diane G; Jaegle, Kate; Nkolola, Joseph P; Peter, Lauren; Fogel, Rachel; Bradshaw, Connor; Tyler, Anna; Makoni, Tatenda; Howe, Lisa; Quijada, Darla; Chandrashekar, Abi... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Issue 10143 (21st July 2018) Authors: Barouch, Dan H; Tomaka, Frank L; Wegmann, Frank; Stieh, Daniel J; Alter, Galit; Robb, Merlin L; Michael, Nelson L; Peter, Lauren; Nkolola, Joseph P; Borducchi, Erica N; Chandrashekar, Abishek; Jetton, David; Stephenson, Kathryn E; Li, Wenjun; Korber, Bette; Tomaras, Georgia D; Montefiori, David C... Journal: Lancet Issue: Volume 392:Issue 10143(2018) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector. (13th April 2018) Authors: Baden, Lindsey R; Walsh, Stephen R; Seaman, Michael S; Cohen, Yehuda Z; Johnson, Jennifer A; Licona, J Humberto; Filter, Rachel D; Kleinjan, Jane A; Gothing, Jon A; Jennings, Julia; Peter, Lauren; Nkolola, Joseph; Abbink, Peter; Borducchi, Erica N; Kirilova, Marinela; Stephenson, Kathryn E; Pegu,... Journal: Journal of infectious diseases Issue: Volume 218:Number 4(2018) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial. Issue 9 (September 2020) Authors: Stephenson, Kathryn E; Tan, Chen Sabrina; Walsh, Stephen R; Hale, Andrew; Ansel, Jessica L; Kanjilal, Diane G; Jaegle, Kate; Peter, Lauren; Borducchi, Erica N; Nkolola, Joseph P; Makoni, Tatenda; Fogel, Rachel; Bradshaw, Connor; Tyler, Anna; Moseley, Edward; Chandrashekar, Abishek; Yanosick, Kath... Journal: Lancet infectious diseases Issue: Volume 20:Issue 9(2020) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗